Won Chul SHİN, Jae Hoon JANG, Han Eol SEO, Kuen Tak SUH, Nam Hoon MOON

Prevalence and clinical impact of sarcopenia in osteoporotic hip fracture: Single center retrospective cohort study

Objective: The study aimed to identify the prevalence of sarcopenia in patients with osteoporotic hip fractures, investigate the anthropometric differences between sarcopenic and non-sarcopenic patients, and evaluate and compare the surgical outcomes between the two groups. Methods: The study included 135 patients (35 men and 100 women; mean age: 74.1 years (range; 25-96)) who received surgical treatment for hip fracture between March 2014 and October 2016 and underwent whole-body dual-energy X-ray absorptiometry (DEXA). The skeletal muscle mass index (SMI) for diagnosis of sarcopenia was measured using whole-body DEXA. The following data were collected to compare the preoperative details of the sarcopenic and non-sarcopenic groups: SMI, age, sex, type of fracture, type of operation, BMI, obesity, American society of Anesthesiologists (ASA) class, pre-injury mobility score, BMD, and follow-up period. We compared clinical outcomes, including Harris Hip Score (HSS) and the walking ability at the last follow-up visit and radiologic outcomes, including non-union and the time to union. Results: The average HHS and Parker’s mobility score at the last follow-up were 81.7 and 6.9 in the sarcopenic group, and 77.6 and 6.3 in the non-sarcopenic group, respectively (p=0.149 and 0.122). Non-union was identified 0 (0%) in sarcopenic group and 4 (10%) in non-sarcopenic group (p=0.288). The mean union timer of the patients in the sarcopenia group was 4.0 months and that of patients in the non-sarcopenic group was 4.4 months (p=0.210). Multiple regression analysis did not show any significant association between sarcopenia and postoperative surgical outcomes, including HHS, mobility score at the last follow up, non-union, and time to union. Conclusion: Although the present study showed that the prevalence of sarcopenia in hip fracture patients was 45.9% (62/135), there was no clinical association between sarcopenia and postoperative. Based on these results, the clinical impact of sarcopenia may be confined to increased risk of hip fracture occurrence and surgical outcomes of hip fracture may not be affected by sarcopenia.

___

Ha YC, Park YG, Nam KW, Kim SR. Trend in hip fracture incidence and mortality in Korea: A prospective cohort study from 2002 to 2011. J Korean Med Sci 2015; 30: 483-8. [CrossRef]

Lloyd BD, Williamson DA, Singh NA, et al. Recurrent and injurious falls in the year following hip fracture: A prospective study of incidence and risk factors from the Sarcopenia and Hip Fracture study. J Gerontol A Biol Sci Med Sci 2009; 64: 599-609. [CrossRef]

Chen LK, Lee WJ, Peng LN, Liu LK, Arai H, Akishita M. Recent advances in Sarcopenia research in Asia: 2016 update from the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2016; 17: 767. [CrossRef]

Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: Consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014; 15: 95-101. [CrossRef]

Yoo JI, Ha YC, Kwon HB, Lee YK, Koo KH, Yoo MJ. High prevalence of Sarcopenia in Korean patients after hip fracture: A case-control study. J Korean Med Sci 2016; 31: 1479-84. [CrossRef]

Ji HM, Han J, Jin DS, Suh H, Chung YS, Won YY. Sarcopenia and sarcopenic obesity in patients undergoing orthopedic surgery. Clin Orthop Surg 2016; 8: 194-202. [CrossRef]

Hida T, Ishiguro N, Shimokata H, et al. High prevalence of sarcopenia and reduced leg muscle mass in Japanese patients immediately after a hip fracture. Geriatr Gerontol Int 2013; 13: 413-20. [CrossRef]

Moreland JD, Richardson JA, Goldsmith CH, Clase CM. Muscle weakness and falls in older adults: A systematic review and meta-analysis. J Am Geriatr Soc 2004; 52: 1121-9. [CrossRef]

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age ageing 2010; 39: 412-23. [CrossRef]

10. Fukumoto S, Martin TJ. Bone as an endocrine organ. Trends Endocrinol Metab 2009; 20: 230-6. [CrossRef]

11. Pratesi A, Tarantini F, Di Bari M. Skeletal muscle: An endocrine organ. Clin Cases Miner Bone Metab 2013; 10: 11-4. [CrossRef]

12. DiGirolamo DJ, Kiel DP, Esser KA. Bone and skeletal muscle: Neighbors with close ties. J Bone Miner Res 2013; 28: 1509-18. [CrossRef]

13. Corrales LA, Morshed S, Bhandari M, Miclau T 3rd. Variability in the assessment of fracture-healing in orthopaedic trauma studies. J Bone Joint Surg Am 2008; 90: 1862-8. [CrossRef]

14. Landi F, Liperoti R, Russo A, et al. Sarcopenia as a risk factor for falls in elderly individuals: Results from the ilSIRENTE study. Clin Nutr 2010; 31: 652-8. [CrossRef]

15. Flicker L, MacInnis RJ, Stein MS, et al. Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J Am Geriatr Soc 2005; 53: 1881-8. [CrossRef]

16. Hida T, Ishiguro N, Shimokata H, et al. High prevalence of sarcopenia and reduced leg muscle mass in Japanese patients immediately after a hip fracture. Geriatr Gerontol Int 2013; 13: 413-20. [CrossRef]

17. Di Monaco M, Castiglioni C, Vallero F, Di Monaco R, Tappero R. Sarcopenia is more prevalent in men than in women after hip fracture: A cross-sectional study of 591 inpatients. Arch Gerontol Geriat 2012; 55: 48-52. [CrossRef]

18. Gonzalez-Montalvo JI, Alarcon T, Gotor P, et al. Prevalence of sarcopenia in acute hip fracture patients and its influence on short-term clinical outcome. Geriatr Gerontol Int 2016; 16: 1021-7. [CrossRef]

19. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci 2002; 57: 772-7. [CrossRef]

20. van den Beld AW, de Jong FH, Grobbee DE, Pols HAP, Lamberts SWJ. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocr Metab 2000; 85: 3276-82. [CrossRef]

21. Perry HM, Miller DK, Patrick P, Morley JE. Testosterone and leptin in older African-American men: Relationship to age, strength, function, and season. Metabolism 2000; 49: 1085-91. [CrossRef]

22. Sih R, Morley JE, Kaiser FE, Perry HM, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial. J Clin Endocr Metab 1997; 82: 1661-7. [CrossRef]

23. Morley JE, Perry HM, Kaiser FE, et al. Effects of Testosterone replacement therapy in old hypogonadal males - a preliminary-study. J Am Geriatr Soc 1993; 41: 149-52. [CrossRef]

24. Ho AWH, Lee MML, Chan EWC, et al. Prevalence of pre-sarcopenia and sarcopenia in Hong Kong Chinese geriatric patients with hip fracture and its correlation with different factors. Hong Kong Med J 2016; 22: 23-9. [CrossRef]